Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 6Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Carcinoma, Ovarian Epithelial 5Breast Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Rectal Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hodgkin Disease 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Colonic Neoplasms 3Burkitt Lymphoma 3Bile Duct Neoplasms 3Anus Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Polymerase Chain Reaction 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Interleukin-12 Subunit p35 × Clear all
NCT00020449 2013-06-19

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡